Skip to content

Effect of Liposomal Bupivacaine Transversus Abdominis Plane Block on Early Postoperative Renal Function Recovery in Kidney Transplant Recipients: A Single-Center, Randomized, Single-Blind, Active-Controlled Clinical Trial

Effect of Liposomal Bupivacaine Transversus Abdominis Plane Block on Early Postoperative Renal Function Recovery in Kidney Transplant Recipients: A Single-Center, Randomized, Single-Blind, Active-Controlled Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600127794
Enrollment
Unknown
Registered
2026-07-07
Start date
2027-01-01
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients undergoing their first allogeneic kidney transplantation

Interventions

Intervention group:Ultrasound-guided transversus abdominis plane block (TAP) was performed on the surgical side. 10ml of 1.3% bupivacaine liposome and 20ml of normal saline were injected. The needle t
Control group:30ml of traditional 0.25% bupivacaine was used, and the operation norms were the same as those of the experimental group.

Sponsors

The First Affiliated Hospital of Xi'an Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-65 years; 2. BMI 18.5-28 kg/m^2; 3. ASA class II-III; 4. Diagnosed with end-stage renal disease (eGFR 3 months); 5. Receiving a first allogeneic kidney transplant; 6. Cold ischemia time of the donor kidney <=24 hours; 7. Planned to undergo retroperitoneal approach kidney transplantation; 8. Resting systolic blood pressure <=160 mmHg and diastolic blood pressure <=100 mmHg; 9. Discontinue NSAIDs 72 hours before surgery.

Exclusion criteria

Exclusion criteria: 1. Received iodinated contrast agent examination within 72 hours before kidney transplantation (serum creatinine fluctuation >=0.3 mg/dL); 2. Multiple renal artery anastomoses (>=3 vessels) or intraoperative hypersensitivity reaction (pathologically confirmed); 3. Long-term opioid dependence (>30 mg/day morphine equivalent for >=1 month); 4. Abnormal coagulation: INR>1.5 or platelet count <80×10^9/L; 5. History of abdominal surgery: metal implants/extensive adhesions in the block area; 6. History of local anesthetic allergy: history of allergic reaction to bupivacaine/ropivacaine.

Design outcomes

Primary

MeasureTime frame
The 72-hour postoperative creatinine decline rate (?Cre72 = (Cre24 ? Cre72) × 100 / Cre24);

Secondary

MeasureTime frame
72-hour postoperative cumulative opioid consumption (in morphine equivalents);Respiratory depression event;Estimated glomerular filtration rate (eGFR) on postoperative day 7;48-hour postoperative serum NGAL;Postoperative pain scores at rest and during cough at 24, 48, and 72 hours (Numerical Rating Scale, NRS);Incidence of postoperative nausea and vomiting (PONV);Cumulative number of rescue analgesia episodes within 72 hours postoperatively.;24-hour postoperative urinary a-GST/p-GST;Incidence of delayed graft function (DGF);Manifestations of local anesthetic-induced neurotoxicity;The 48-hour postoperative creatinine decline rate (?Cre48 = (Cre24 ? Cre48) × 100 / Cre24);

Countries

China

Contacts

Public ContactDu Hailiang

The First Affiliated Hospital of Xi'an Jiaotong University

duhailiang@xjtu.edu.cn+86 29 85323646

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026